Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC41342
Terrecyclic Acid
环酸A
A sesquiterpene -
GC41341
Quadrone
夸德尔酮
A sesquiterpene with anticancer activity -
GC41340
Illudin M
隐陡头菌素M
A DNA alkylating agent - GC41317 CAY10625 An inhibitor of survivin - Smac/DIABLO interaction
-
GC41268
(E)-2-Hexadecenal
trans-2-Hexadecenal
A long-chain fatty aldehyde -
GC41261
Flavokawain B
黄卡瓦胡椒素B,Flavokavain B
Induces cancer cell apoptosis -
GC41183
α-Carotene
α-胡萝卜素
A precursor of vitamin A -
GC41114
Necrostatin-5
2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-D]嘧啶-2-基]硫代]-乙腈
A RIP1 kinase inhibitor -
GC41112
Dihydroxy Melphalan
二羟基美法兰
An inactive degradation product of melphalan -
GC41102
15-deoxy-δ12,14-Prostaglandin D2
15deoxyΔ12,14PGD2
A metabolite of PGD2 and an agonist of DP2 -
GC41080
Albofungin
白真菌素
A xanthone with diverse biological activities -
GC40986
Cinnamamide
肉桂酰胺
An amide of trans-cinnamic acid -
GC40947
2,3-Dimethoxy-5-methyl-p-benzoquinone
2,3-二甲氧基-5-甲基-1,4-苯醌,CoQ0
An intermediate in the synthesis of ubiquinones that has anticancer activity -
GC40932
S-trityl-L-Cysteine
NSC 83265; S-Tritylcysteine; 3-Tritylthio-L-alanine
An inhibitor of Eg5 -
GC40909
Lonicerin
忍冬苦苷
A flavonoid with diverse biological activities -
GC40901
Isogarcinol
Cambogin
A natural benzophenone that has immunosuppressant actions -
GC40878
Chelidonine
白屈菜碱
A tertiary hexahydro-benzophenanthridine alkaloid -
GC40872
Zinquin ethyl ester
乙基2-(2-甲基-8-(4-甲基苯基磺酸基N乙酰胺基)喹啉-6-氧基)乙酸酯
A fluorescent probe for zinc - GC40865 LYG-202 A synthetic flavonoid with anticancer and anti-angiogenic activities
-
GC40861
Pinosylvin
赤松素
A stilbene with diverse biological activities -
GC40859
Steffimycin B
司替霉素B
An anthracycline bacterial metabolite - GC40791 MS-1020 A cell-permeable inhibitor of JAK3
-
GC40785
9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester
αESA ethyl ester, Ethyl αeleostearate
A polyunsaturated fatty acid ethyl ester -
GC40760
Nonanoic Acid methyl ester
壬酸甲酯
An esterified form of nonanoic acid -
GC40758
Gly-Phe-β-naphthylamide
(S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺
A cathepsin C substrate -
GC40715
Ascochlorin
壳二孢氯素,Ilicicolin D
An isoprenoid antibiotic and antiviral -
GC40710
9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester
9顺,11反,13反-十八碳三烯酸甲酯
A polyunsaturated fatty acid methyl ester -
GC40698
(-)-Perillyl Alcohol
紫苏醇
A monoterpene alcohol with diverse biological activities -
GC40690
C6 L-threo Ceramide (d18:1/6:0)
L-threo Cer(d18:1/6:0), L-threo Ceramide (d18:1/6:0), N-hexanoyl-L-threo-Sphingosine
A bioactive sphingolipid -
GC40689
C6 L-erythro Ceramide (d18:1/6:0)
L-erythro Cer(d18:1/6:0), L-erythro Ceramide (d18:1/6:0), N-hexanoyl-L-erythro-Sphingosine
A bioactive sphingolipid -
GC40688
C6 D-threo Ceramide (d18:1/6:0)
N-hexanoyl-D-threo-Sphingosine, D-threo Cer(d18:1/6:0), D-threo Ceramide (d18:1/6:0)
A bioactive sphingolipid -
GC40675
2-deoxy-Artemisinin
脱氧青蒿素
An inactive metabolite of artemisinin -
GC40673
Geranyl Acetate
乙酸香叶酯
A monoterpene with diverse biological activities -
GC40669
Nerol
橙花醇
A monoterpene -
GC40664
Colcemid
秋水仙碱,Demecolcine
Colcemid是一种细胞骨架抑制剂,可以在哺乳动物细胞或卵母细胞中诱导G2/M期的有丝分裂停滞或囊泡破裂(GVBD)期的减数分裂停滞。 -
GC40655
NVP-BKM120
布帕尼西; BKM120; NVP-BKM120
An inhibitor of class I PI3K isoforms - GC40650 CAY10706 A TrxR inhibitor
-
GC40614
Anhydroepiophiobolin A
3-Anhydro-6-epi-ophiobolin A
A sesterterpenoid fungal metabolite -
GC40556
Ac-LETD-AFC
NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)
A caspase-8 fluorogenic substrate -
GC40483
Patulin
棒曲霉素; Terinin
A mycotoxin
-
GC40334
Myristoleic Acid methyl ester
肉豆蔻脑酸甲酯
Methyl ester of the cytotoxin myristoleic acid -
GC19541
(rac)-Antineoplaston A10
3-苯基乙酰氨基-2,6-哌啶二酮
(rac)-Antineoplaston A10 是 Antineoplaston A10 的外消旋体。 Antineoplaston A10 是一种潜在的 Ras 抑制剂,可用于治疗神经胶质瘤、淋巴瘤、星形细胞瘤和乳腺癌。 -
GC19537
β-Elemene
β-榄香烯; (-)-β-Elemene; Levo-β-elemene
An analytical standard for the detection of β-elemene -
GC19533
Infliximab
英夫利昔单抗,Avakine; CT-P13
英夫利昔单抗是一种嵌合单克隆 IgG1 抗体,可特异性结合 TNF-α。
-
GC19531
Pembrolizumab
派姆单抗,帕博利珠单抗,Lambrolizumab; MK-3475
Pembrolizumab 是一种抗程序性死亡 1 单克隆抗体,已在晚期实体癌患者中证明具有临床显着的抗肿瘤活性和可接受的安全性,并已被美国 FDA 批准用于治疗晚期黑色素瘤、NSCLC、头颅和脑肿瘤。 - GC34929 PD-1-IN-17 TFA An inhibitor of PD-1 signaling
- GC34928 PD-1-IN-17 An inhibitor of PD-1 signaling
-
GC34862
WYC-209
4,5-二(羟甲基)-2-苯基-1H-咪唑
WYC-209是一种合成类视黄醇,能抑制恶性小鼠黑色素瘤肿瘤再生细胞(TRC)的增殖,IC50值为0.19μM。WYC-209主要细胞靶点是维甲酸受体(RARs)。 -
GC34831
Tauroursodeoxycholate dihydrate
牛磺熊去氧胆酸二水合物; Tauroursodeoxycholic acid dihydrate; TUDCA dihydrate; UR 906 dihydrate
Tauroursodeoxycholatedihydrate(TUDCAdihydrate;UR906dihydrate;Taurolitedihydrate)是一种内质网应激抑制剂。Tauroursodeoxycholate显著降低凋亡分子如caspase-3和caspase-12表达。Tauroursodeoxycholate也抑制ERK。 - GC34642 KI696 isomer KI696isomer是KI696的低活性异构体。KI696是一种高亲和力探针,可破坏Keap1/NRF2相互作用。